What is Mounjaro 2.5 mg Vial?
Mounjaro 2.5 mg Vial is a prescription injectable medicine containing tirzepatide 2.5 mg/0.5 mL. It is the starting dose of Mounjaro and is injected once weekly under the skin. It is used to improve blood sugar control in adults with Type 2 diabetes and, where approved, to support chronic weight management in eligible adults. The 2.5 mg dose is intended to help the body adjust to treatment and is not meant to provide full blood sugar control on its own.
Active Ingredient
- Generic Name: Tirzepatide
- Strength: 2.5 mg/0.5 mL
- Dosage Form: Single-dose vial for subcutaneous injection
- Drug Class: Dual GIP and GLP-1 receptor agonist
- Route of Administration: Subcutaneous injection (abdomen, thigh, or upper arm)
Uses of Mounjaro 2.5 mg Vial
Mounjaro 2.5 mg is prescribed to:
- Improve blood sugar control in adults with Type 2 diabetes
- Support long-term diabetes management with diet and exercise
- Help reduce appetite and calorie intake
- Promote gradual weight loss in eligible patients
- Prepare patients for higher maintenance doses (5 mg and above)
How Does It Work?
Tirzepatide works by activating both GIP and GLP-1 receptors. This helps:
- Increase insulin release when blood sugar is high
- Reduce glucagon production by the liver
- Slow stomach emptying
- Reduce hunger and food cravings
- Improve blood sugar control and aid weight loss over time.
Dosage
Recommended Starting Dose
- 2.5 mg injected once weekly
- Continue for 4 weeks
- After 4 weeks, increase to 5 mg once weekly if recommended by your healthcare provider.
- Inject on the same day each week, with or without food.
- Do not increase the dose sooner than advised.
How to Use the Vial
- Wash your hands thoroughly.
- Inspect the vial; the solution should be clear and colorless to slightly yellow.
- Use a new sterile syringe and needle.
- Draw up the prescribed dose as instructed by your healthcare provider.
- Inject under the skin of the abdomen, thigh, or upper arm.
- Rotate injection sites each week.
- Discard the vial after use if it is a single-dose vial. Do not reuse needles or syringes.
Common Side Effects
- Nausea
- Vomiting
- Diarrhea
- Constipation
- Stomach pain
- Indigestion
- Loss of appetite
- Injection-site redness or itching
- Fatigue
These effects are usually mild and improve as treatment continues.
Serious Side Effects
Seek medical attention immediately if you experience:
- Severe stomach pain (possible pancreatitis)
- Persistent vomiting or dehydration
- Difficulty breathing or severe allergic reaction
- Signs of gallbladder disease
- Kidney problems
- Vision changes
- Symptoms of low blood sugar when used with insulin or sulfonylureas
- Neck swelling or a lump that could indicate a thyroid problem.
Warnings
Do not use Mounjaro if you:
- Have a personal or family history of medullary thyroid carcinoma (MTC)
- Have Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
- Are allergic to tirzepatide or any ingredient in the product.
Use with caution if you have:
- Pancreatitis
- Kidney disease
- Gallbladder disease
- Severe digestive disorders
- Diabetic retinopathy.
Precautions
Before starting treatment:
- Tell your doctor about all medicines and supplements you take.
- Monitor your blood sugar regularly.
- Stay well hydrated, especially if you have nausea or diarrhea.
- Follow a healthy diet and exercise plan.
- Do not share your syringe or needle.
- Rotate injection sites to reduce skin irritation.
- Avoid changing your dose without medical advice.
Storage
- Store in a refrigerator at 2°C to 8°C.
- Do not freeze.
- Keep the vial in its original carton to protect it from light.
- If necessary, a single-dose vial may be kept at room temperature (up to 30°C) for up to 21 days.
Missed Dose
- If you remember within 4 days (96 hours), take the missed dose as soon as possible.
- If more than 4 days have passed, skip the missed dose and take your next dose on the regular schedule.
- Never take two doses within 3 days of each other.
FAQs
1. What is Mounjaro 2.5 mg Vial used for?
It is the starting dose used to improve blood sugar control in Type 2 diabetes and to begin treatment for eligible patients needing weight management.
2. Is 2.5 mg the maintenance dose?
No. It is an initiation dose used for the first 4 weeks before increasing to 5 mg if appropriate.
3. How often should I inject Mounjaro 2.5 mg?
Once every week on the same day.
4. Can I inject it with or without food?
Yes. It can be taken with or without meals.
5. Where should I inject the medicine?
Into the abdomen, thigh, or upper arm, rotating injection sites each week.
6. What are the most common side effects?
Nausea, vomiting, diarrhea, constipation, stomach discomfort, and reduced appetite.
7. Can Mounjaro 2.5 mg help with weight loss?
Yes. It may help reduce appetite and support gradual weight loss, although the starting dose is primarily intended to help your body adjust to treatment before dose escalation.
